Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines

Manisha H. Shah, Whitney S. Goldner, Thorvardur R. Halfdanarson, Emily Bergsland, Jordan D. Berlin, Daniel Halperin, Jennifer Chan, Matthew H. Kulke, Al B. Benson, Lawrence S. Blaszkowsky, Jennifer Eads, Paul F. Engstrom, Paul Fanta, Thomas Giordano, Jin He, Martin J. Heslin, Gregory P. Kalemkerian, Fouad Kandeel, Sajid A. Khan, Wajih Zaheer KidwaiPamela L. Kunz, Boris W. Kuvshinoff, Christopher Lieu, Venu G. Pillarisetty, Leonard Saltz, Julie Ann Sosa, Jonathan R. Strosberg, Craig A. Sussman, Nikolaos A. Trikalinos, Nataliya A. Uboha, Jonathan Whisenant, Terence Wong, James C. Yao, Jennifer L. Burns, Ndiya Ogba, Griselda Zuccarino-Catania

Research output: Contribution to journalReview articlepeer-review

126 Scopus citations

Abstract

The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET. These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs.

Original languageEnglish (US)
Pages (from-to)693-702
Number of pages10
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume16
Issue number6
DOIs
StatePublished - Jun 1 2018

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines'. Together they form a unique fingerprint.

Cite this